SNW1 is a prognostic biomarker in prostate cancer

Doris Höflmayer,Carla Willich,Claudia Hube-Magg,Ronald Simon,Dagmar S. Lang,Emily Neubauer,Frank Jacobsen,Andrea Hinsch,Andreas M. Luebke,Marie Christina Tsourlakis,Hartwig Huland,Markus Graefen,Alexander Haese,Hans Heinzer,Sarah Minner,Franziska Büscheck,Guido Sauter,Thorsten Schlomm,Stefan Steurer,Till S. Clauditz,Eike Burandt,Waldemar Wilczak,Christian Bernreuther

SNW1 is a prognostic biomarker in prostate cancer

2019

Background SNW1 is a nuclear receptor co-activator involved in splicing and transcription control, including androgen receptor signaling. Overexpression of SNW1 has been linked to adverse prognosis in different cancer types, but studies on the role of SNW1 in prostate cancer are lacking.

Keywords:

Androgen receptor
Nuclear receptor
RNA splicing
Pathology
Prostate cancer
Cancer
Biomarker (medicine)
Cancer research
Transcription (biology)
Medicine
TMPRSS2
Biochemical recurrence
Tissue microarray
Oncology
Erg
Prostate
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations